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Abstract
Progranulin haplo-insufficiency is a main cause of frontotemporal lobar degeneration (FTLD) with TDP-43 aggregates.
Previous studies have shown that sortilin regulates progranulin trafficking and is a main determinant of progranulin level in
the brain. In this study, we mapped the binding site between progranulin and sortilin. Progranulin binds to the beta-
propeller region of sortilin through its C-terminal tail. The C-terminal progranulin fragment is fully sufficient for sortilin
binding and progranulin C-terminal peptide displaces progranulin binding to sortilin. Deletion of the last 3 residues of
progranulin (QLL) abolishes its binding to sortilin and also sortilin dependent regulation of progranulin trafficking. Since
progranulin haplo-insufficiency results in FTLD, these results may provide important insights into future studies of
progranulin trafficking and signaling and progranulin based therapy for FTLD.
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Introduction
Frontotemporal lobar degeneration (FTLD) is one of the most
prevalent forms of early onset dementia (45–65 years of age),
second only to Alzheimer’s disease [1,2]. Clinical features of
FTLD include memory deficits, behavioral abnormalities, person-
ality changes and language impairments [3]. Mutations in the
Progranulin (PGRN) gene were recently shown to be a common
cause of FTLD and the major cause of FTLD with tau-negative
ubiquitin positive inclusions [4,5,6]. So far 68 distinct PGRN
mutations have been found in 229 families (http:// www.molgen.
ua.ac.be/FTDMutations), responsible for 5–10% of all FTLD
cases. Most mutations result in a decrease in the amount of
progranulin expressed or secreted, rather than a gain of toxicity
[4,5]. Thus progranulin haplo-insufficiency is strongly associated
with FTLD [4,5].
Progranulin is an evolutionarily conserved, secreted glycoprotein
that can be proteolytically processed into several granulin peptides
(granulins A, B, C, D, E, F, G) [7]. It regulates cell proliferation, cell
mobility, inflammation and wound healing [8,9]. The normal
functionsofprogranulininthe central nervoussystem(CNS)remain
to be defined, although studies have suggested a role of progranulin
in promoting neuronal survival and regulating inflammation in the
CNS [10,11,12,13,14,15]. Moreover, mechanisms that regulate
progranulin levels and the receptor(s) and signaling pathways
involved in progranulin action remain to be defined.
Sortilin was recently identified as a progranulin binding partner
in an expression cloning screen [16]. Sortilin is a type I single pass
transmembrane protein in the VPS10 family which regulates
intracellular protein trafficking and acts as a cell surface receptor
that mediates pro-NGF and pro-BDNF mediated cell death when
coupled with p75/NTR [17]. Sortilin mediates progranulin
endocytosis and regulates the level of progranulin in the brain
[16]. The level of secreted progranulin is dramatically increased in
sortilin knockout mice [16]. Furthermore, ablation of sortilin is
able to correct the decreased progranulin level in mice
heterozygous for PGRN deletion [16]. A genome wide association
study has also found two SNPs close to sortilin that affect sortilin
expression associated with PGRN level in the plasma [18]. Thus
progranulin-sortilin interaction is a major determinant of pro-
granulin level in vivo.
Here we report the mapping of the binding sites between
progranulin and sortilin. We show that progranulin binds to the
beta propeller region of sortilin through its C-terminal tail. The
crystal structure of the VPS10 domain of sortilin was recently
determined in a complex with another sortilin ligand, neurotensin
[19]. Neurotensin, a brain-gut tridecapeptide, interacts with the
sortilin beta-propeller domain via its extreme carboxyl terminus.
Our data suggests that progranulin and neurotensin interact with
sortilin in a similar fashion.
Results
Progranulin binds to the beta-propeller region of sortilin
Sortilin is a multi-functional receptor that interacts with an
increasing number of ligands [17]. The VPS10 domain of sortilin
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21023consists of two structural modules, a ten-bladed beta-propeller
structure at the N-terminus (residues 81–611) and a cysteine rich
10CC module (10CCa and 10CCb, residues 612–757) at the C-
terminus [19]. To determine which structural domain of sortilin is
involved in progranulin binding, we expressed the beta-propeller
region or the 10CC region of sortilin fused to the transmembrane
domain of PDGFR. While the full length VPS10 domain and
beta-propeller region of sortilin could support progranulin binding
when expressed on the cell surface, the 10CC domain failed to
bind to progranulin. The beta-propeller and 10CC regions showed
similar expression levels in the cell by both immunofluorescence
staining and western blot (Fig. 1A and 1B). This suggests that
progranulin interacts with the beta-propeller domain of sortilin but
not the 10CC region.
Two modes of interaction between sortilin and its ligands have
been demonstrated. The C-terminal residues of neuropeptide
neurotensin (PYIL) bind inside the tunnel of the beta-propeller,
interacting with blades 5–6 in the beta-propeller region of VPS10
[19]. Serine 283 of sortilin makes hydrogen bonds with the C-
terminal carboxylate of neurotensin through its side chains [19].
S283E mutation abolishes neurotensin binding to sortilin [19]. On
the other hand, the pro-domains of nerve growth factor (NGF) and
brain derived neurotrophic factor (BDNF) bind to sortilin through
a linear surface exposed sequence [20] and the S283E mutation of
sortilin has no effect on pro-NGF or pro-BDNF binding [19]. We
found that the S283E mutation in the beta-propeller region of
sortilin abolishes progranulin binding (Fig. 1C and 1D), suggesting
that progranulin binds to sortilin in a manner similar to
neurotensin.
The C-terminus of progranulin mediates its binding to
sortilin
In order to determine regions in progranulin responsible for
sortilin binding, we made a series of deletion constructs. Granulin E
and its flanking region (C100, aa 494–593) have been shown to be
fully sufficient for binding to sortilin while the rest of the mature
progranulin protein (aa 18–494) does not bind to sortilin [16]. Since
the last three residues of progranulin (QLL) are similar to those of
neurotensin (YIL), we propose that progranulin might interact with
sortilin through its C-terminal residues like neurotensin. Indeed, we
found that deletion of the last 3aa of progranulin (residues QLL)
(PGRND3aa)abolishesprogranulinbindingtosortilinintheCOS-7
binding assay (Fig. 2A and 2B) and in the co-immunoprecipitation
experiment (Fig. 2D), supporting a critical role of these residues in
mediating progranulin-sortilin interaction. To determine whether
theC-terminal tailofprogranulinissufficient forsortilinbinding,we
made N-terminal alkaline phosphatase (AP) fusion proteins with the
last24, 9 or6 residuesof progranulin.We found that thelast 24aa of
progranulin (C24, aa 570–593) is fully sufficient for binding to
sortilin (Fig. 2A–C). Alkaline phosphatase tagged C24 binds to
sortilin with a Kd in the nM range, similar to C100 and full length
progranulin [16] (Fig. 2C). The fusion of the C-terminal 9 residues
(C9) or 6 residues (C6) of progranulin to AP also enables the fusion
protein to interact with sortilin, suggesting that the last 6 residues
Figure 1. Progranulin interacts with the beta-propeller region of sortilin. (A) A schematic drawing of sortilin fragments cloned in the
pDisplay vector (full length sortilin ecto domain (residues 81–757), sortilin 10CC region (residues 612–757) or sortilin beta propeller domain (residues
81–611)) and western blot to confirm their expression levels in COS-7 cells using anti-myc antibodies. (B) Binding of 100 nM alkaline phosphatase
tagged progranulin (AP-PGRN) to COS-7 cells expressing various sortilin construct as indicated. Expression of these constructs was verified by anti-
myc staining. (C) S283E mutation of sortilin abolished progranulin binding. Cell lysates from HEK293T cells transfected with vector control, wild type
sortilin or the S283E mutant of sortilin were incubated with anti-Flag beads bound to Flag-PGRN. The presence of sortilin in the 3% input and anti-
Flag IP was detected using anti-sortilin antidodies. (D) COS-7 cells expressing wild type sortilin or sortilin S283E mutant were allowed to bind to
100 nM AP-PGRN. The expression of S283E mutant was confirmed with western blot using anti-sortilin antibodies. Scale bar=100 mm.
doi:10.1371/journal.pone.0021023.g001
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PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e21023Figure 2. Progranulin C-terminus mediates its binding to sortilin. (A) COS-7 cells expressing wild type sortilin were allowed to bind AP
tagged progranulin fragments as indicated. (B) Quantification of the binding assay as described in (A). The intensity of AP staining was measured
using the Metaexpress software (Y axis: average integrated optical density per cell (6100)). (C) C24 fragment of progranulin binds to sortilin with a
similar affinity as the C100 fragment and full length progrnaulin. Sortilin expressing COS-7 cells were allowed to bind to AP tagged C100 and C24 at
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although not to the same extent as the 24 residues (Fig. 2E and 2F).
Steric hindrance due to the AP fusion might reduce the flexibility
and binding affinity of the C9 and C6 peptide to sortilin. The C-
terminal carboxylate of leucine residue was shown to be critical for
neurotensin-sortilin binding [19]. We found that addition of
residues to the progranulin C-terminus (+7aa) abolishes the binding
of progranulin to sortilin, further confirming a critical role of
progranulin’s C-terminal leucine residue in mediating its binding to
sortilin (Fig.2E,2F).Westernblotanalysisshowedproper molecular
weight for all the AP-fusion proteins used in our study (Fig. S1).
Furthermore, binding of alkaline phosphatase tagged C24
fragment (AP-C24) and full length progranulin (AP-PGRN) to
sortilin can be efficiently displaced by recombinant histidine
tagged full length progranulin (his-PGRN) and the C18 peptide C-
terminal to the granulin E motif (Fig. 3A and 3B). Deletion of the
last 3 residues from the recombinant his-PGRN protein
(PGRND3aa) dramatically reduced its ability to compete with
AP-PGRN for binding to sortilin (Fig. 3). The C-terminal 6
residues of neurotensin also displace binding of progranulin to
sortilin [16]. These data further support that the C-terminal tail of
progranulin is responsible for progranulin-sortilin interaction and
progranulin binds to sortilin in a manner similar to neurotensin.
Conservation of sortilin binding motifs in progranulin
We modeled progranulin binding to sortilin according to the co-
crystal structure of sortilin and neurotensin. Like neurotensin, the
C-terminalcarboxylateofprogranulinmakesmostcontactswith the
beta-propeller structure of sortilin (Fig. 4A). The C-terminal leucine
fits into a hydrophobic pocket of sortilin surrounded by residues
F281, S283, R292, Y318 and S319, forms a salt bridge with the
guanidinium group of R292 and makes hydrogen bonds with the
side chain of S283 and the main chain amide of Y318. Alignment of
progranulin sequences from mammals revealed the conservation of
the C-terminal leucine residue (Fig. 4B). However, it seems there is
no absolute requirement for other residues for sortilin binding
besides the C-terminal leucine. Deletion of the last 3 residues (PLL)
in the C-terminal 24 residues of mouse progranulin abolishes its
binding to sortilin, supporting that PLL in mouse progranulin
mediates its binding to sortilin (Fig. 4C). Thus YIL in neurotensin,
QLL in human progranulin as well as PLL in mouse progranulin all
mediate binding to sortilin, suggesting a great flexibility in the
residue requirement for sortilin interaction other than the C-
terminal leucine as long as the C-terminal tail of the protein can fit
into the hydrophobic pocket of sortilin.
Sortilin regulated progranulin trafficking is abolished by
C-terminal deletion of progranulin
Sortilin reduces the extracellular level of progranulin, possibly
through active endocytosis and sorting in the TGN [16]. When
sortilin is overexpressed in HEK293T cells, the extracellular level
of progranulin is dramatically reduced compared to vector control
[16] (Fig. 5A). However, when PGRND3aa is co-transfected with
sortilin or when full length PGRN is co-transfected with S283E
mutant of sortilin, this effect of sortilin on progranulin is totally
abolished (Fig. 5A). The same effect was observed in the
neuroblastoma cell line N2A (Fig. 5A). Thus progranulin is no
longer subject to sortilin mediated trafficking when the interaction
of PGRN and sortilin is abolished by deleting the last 3 residues of
progranulin or mutating the serine 283 to glutamate in sortilin.
Although the progranulin C-terminal tail is critical for sortilin
interaction, it is not required for its secretion in the constitutive
secretion pathway. When transfected into HEK293T cells or N2A
cells, deletions or additions in the C-terminal tail that abolish
progranulin binding to sortilin do not affect progranulin secretion
into the medium (Fig. 5B), while deletion of part of granulin E
segment (-43aa) results in retention of progranulin inside of the
cell, suggesting that the progranulin C-terminal tail is not required
for constitutive progranulin secretion.
Discussion
In this study, we show that the binding between progranulin
and sortilin is mediated by the C-terminal tail of progranulin and
the beta-propeller region of sortilin. Progranulin binds to sortilin in
a manner similar to neurotensin: (1) S283E mutation of sortilin
abolishes progranulin binding, as well as neurotensin binding, but
does not affect pro-neurotrophin binding; (2) Progranulin C-
terminal tail is sufficient to mediate sortilin interaction and the last
increasing concentrations. Scatchard plot was used to determine the Kd of the binding. (D) Flag tagged PGRN and C100 but not PGRND3aa or C97
pull down sortilin in the cell lysates of NSC-34, a motor neuron cell line. (E) Alkaline phosphatase fused full length PGRN, C-terminal C100, C9 or C6
proteins binds to sortilin expressed in COS-7 cells at 100 nM, but not full length PGRN protein with additional 7 residues (GPMHETR) at its C-terminus.
(F) Quantification of binding intensity for the experiment in (E) using the MetaXpress software. Scale bar=100 mm.
doi:10.1371/journal.pone.0021023.g002
Figure 3. Progranulin C-terminal peptide displaces progranulin
binding to sortilin. (A) Alkaline phosphatase fused full length PGRN
and C24 binding to sortilin can be displaced by purified recombinant
his-PGRN, C18 peptide (EAPRWDAPLRDPALRQLL) but not by his-
PGRND3aa. Sortilin expressing COS-7 cells were incubated with
150 nM purified his-PGRN, his-PGRND3aa or C18 peptide of indicated
concentrations for 1 hour before adding 10 nM of AP-PGRN or AP-C24.
(B) Quantification of binding intensity for experiments in (A) using the
ImageXpress system. Scale bar=100 mm. *, p,0.05;**, p,0.01, n=3–6,
paired Student’s T-test.
doi:10.1371/journal.pone.0021023.g003
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sortilin, which are similar to the amino acid composition of
neurotensin C-terminal residues (YIL).
Since progranulin haplo-insufficiency is a leading cause of FTLD
and sortilin is a main determinant of progranulin level,reagents that
modulate progranulin-sortilin interaction and thus help restore
progranulin levels in the brain might be of high therapeutic interest.
Our study demonstrated a critical role of the progranulin C-
terminal tail in mediating its interaction with sortilin and thus an
important function of this fragment in controlling progranulin
trafficking. This result will impact future experiments with
progranulin gene therapy or protein administration to treat FTLD.
By deleting the last 3 residues of progranulin, higher levels of
progranulin in the brain could be possibly achieved by bypassing
sortilinmediatedregulation ofprogranulintrafficking and lysosomal
degradation. However, it is still not clear whether the progranulin-
sortilin interaction also plays a role in progranulin signaling. Future
studies are required to determine whether sortilin mediates the
reported effects of progranulin on neuronal survival and inflam-
mation. We have also found that the C-terminal carboxylate of
progranulin in crucial in mediating the interaction between
progranulin and sortilin. Addition of 7 residues at the C-terminus
abolished progranulin binding to sortilin (Fig. 2E). Thus C-terminal
tagging of progranulin should be avoided in order to preserve the
interaction between progranulin and sortilin.
Since the minimum requirement for sortilin binding is fairly
degenerate, our study also raises the question about the specificity
of the progranulin-sortilin interaction. Progranulin does not
interact with other mammalian sortilin homologs, such as sorLA
and sorCS1 [16], suggesting that the specific organization of the
sortilin beta-propeller region is required for this binding to occur.
Sortilin is a multi-functional receptor with many identified ligands.
Some of the ligands, such as cathepsin D also have C-terminal
leucine residues (gi|179948, human cathepsin D, ARL and
gi|817945, mouse cathepsin D, VVL). While it remains to be
determined whether cathepsin D interacts with sortilin through its
C-terminal leucine residue, there might be other unknown ligands
for sortilin that bind through similar mechanisms.
The C-terminal peptide of progranulin is the only binding site
for sortilin in progranulin. The granulin motif does not bind to
sortilin and possesses unique biological activities in proliferation,
inflammation and wound healing [7,8,9]. This indicates there exist
other receptors that mediate the effects of progranulin or its
cleaved products, granulin peptides. In this regard, a recent study
demonstrated direction interactions between progranulin and
tumor necrosis factor receptors [21].
Our study also suggests that progranulin and pro-neurotrophins
binds to sortilin through different sites. The pro-domain of nerve
growth factor (NGF) and brain derived neurotrophic factor
(BDNF) binds to sortilin through a linear surface exposed sequence
[20] rather than interacting inside of the beta-propeller tunnel like
neurotensin and progranulin. This binding motif is consistent with
the published data that progranulin and pro-NGF can bind to
sortilin simultaneously in a Surface Plasmon Resonance experi-
ment [16]. However, neurotensin blocks pro-neurotrophin
induced neuronal cell death through sortilin although it binds to
a different site. High levels of pro-NGF could also displace
progranulin binding to sortilin [16]. These data suggest that
although progranulin and pro-neurotrophins interact with sortilin
through different mechanisms, steric hindrance and possible
effects on the assembly of the ligand-receptor signaling complex
is still likely to happen with regards to progranulin affecting pro-
neurotrophin binding to sortilin and signaling.
Materials and Methods
Plasmids
To generate AP fusion proteins, human progranulin coding
sequence for corresponding fragments were amplified and ligated
to the pAP5-tag vector (GenHunter, Nashville, TN) digested with
restriction enzymes XhoI and PmeI or XhoI and ApaI. Plasmids
were then transfected into HEK293T cells and conditioned media
were collected after 5 days.
Figure 4. The C-terminal carboxylate of progranulin mediates
its binding to sortilin. (A) Illustration of binding of progranulin C-
terminal tail to sortilin. Drawing was made with Pymol software.
Residue backbones of sortilin are labeled in gray and progranulin
labeled in green. (B) Alignment of the C-terminal residues of
progranulin from different species of mammals (from top to bottom:
gi|4504151|[Homo sapiens], gi|114666849|[Pan troglodytes],
gi|296476263|[Bos taurus], gi|224967126|[Mus musculus], gi|204224|[R-
attus norvegicus] ) and neurotensin. (C) Mouse progranulin interacts
with mouse sortilin through its C-terminal tail. COS-7 cells transfected
with mouse sortilin were incubated with 10 or 50 nM of AP tagged C24
and C21 of mouse progranulin (mC24 and mC21) or C24 of human
progranulin (hC24). Scale bar=100 mm.
doi:10.1371/journal.pone.0021023.g004
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platelet derived growth factor receptor (PDGFR) transmembrane
domain, sortilin Ecto domain (aa 81–757), 10CC region (aa 612–
757) or beta-propeller region (aa 81–611) were cloned into the
pDisplay vector (Invitrogen) using SfiI and XmaI sites. S283E was
generated using site directed mutagenesis using the sortilin cDNA
from Origene as the template.
Cell culture procedures
NSC34 [22], N2A, HEK293T and COS-7 cells were grown in
DMEM supplemented with 10% FBS, 1% Penicillin-Streptomycin
at 37uC in a 5% CO2 atmosphere. All cell lines were obtained
from ATCC. Cells were transiently transfected with polyethlye-
neimine (PEI) as described [23].
Binding assays
COS-7 binding assays were done as described [16]. Condi-
tioned media with AP ligands were incubated with untransfected
or sortilin transfected COS-7 cells 2 hrs at room temperature
before fixation and heat inactivation of endogenous AP. Bound AP
to COS-7 cells was measured using the ImageXpress imaging
system (Molecular Devices).
Antibodies
The following antibodies were used in the study: mouse anti-
sortilin antibodies from BD biosciences, goat anti-sortilin antibod-
ies from R&D systems, goat anti-alkaline phosphatase antibodies
from Santa Cruz, rabbit anti-progranulin antibodies from Zymed,
and mouse anti-myc (9E10) antibodies from Sigma-Aldrich.
Immunoprecipitation
Cells were lysed in 50 mM Tris, pH 8.0, 150 mM NaCl,
1%Triton, 0.1% sodium deoxycholate and proteinase inhibitors
(Roche). Mouse anti-Flag conjugated beads (Sigma) were allowed
to bind to Flag-PGRN from the conditioned media of transfected
HEK293T cells. These beads were incubated with cell lysates for
4 hours at 4uC and washed 4 times with the lysis buffer.
Western-blot analysis
Protein samples in SDS sample buffer containing b-mercapto-
ethanol were boiled 10 min and centrifuged 1 min at 12,000 rpm.
Samples were run on 12% polyacrylamide gels and transferred to
Immobilon-FL PVDF membranes (Millipore). Membranes were
blocked with 5% non-fat milk in PBS for 1 hour followed by
incubation with primary antibodies for 2 hr at room temperature or
overnight at 4uC. Membranes were washed for 5 min three times in
Tris-Buffered Saline with 0.1% Tween-20 (TBS-T), incubated with
secondary antibody for 2 hr at room temperature and washed three
more times with TBS-T. Blots were imaged and quantified using an
Odyssey Infrared Imaging System (LI-COR Biosciences).
Supporting Information
Figure S1 Western blot of AP fusion proteins used in the
study. Conditioned medium collected from transfected
HEK293T cells containing indicated progranulin fragments as
AP fusion proteins were subject to SDS-PAGE and western blot
using anti-AP antibodies.
(TIF)
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Figure 5. Deletion of progranulin C-terminal tail abolishes sortilin dependent control of progranulin trafficking but does not affect
progranulin secretion. (A) Deletion of the PGRN C-terminal 3 residues (PGRND3aa) or S283E mutation in sortilin abolishes sortilin dependent
control of PGRN trafficking. AP tagged full length progranulin (FL), PGRND3aa (-3aa) or AP alone were co-transfected with pcDNA vector control, wild
type or S283E mutant of sortilin into HEK 293T cells or N2A cells. The AP activities in the medium were measured 4 days after transfection. The AP
activities in sortilin expressing cells were expressed as percentage of vector control. *, p,0.05;**, p,0.01, n=3–5, paired Student’s T-test. (B) Deletion
of progranulin C-terminal residues does not affect progranulin secretion. Progranulin expression constructs as AP fusion proteins were transfected in
HEK293T and N2Acells. Progranulin levels in the cell lysates and media were determined by western blots using anti-AP antibodies.
doi:10.1371/journal.pone.0021023.g005
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